{"id":"https://openalex.org/W2810945895","doi":"https://doi.org/10.1016/j.ctrv.2018.06.018","title":"Overview of the LUX-Lung clinical trial program of afatinib for non-small cell lung cancer","display_name":"Overview of the LUX-Lung clinical trial program of afatinib for non-small cell lung cancer","publication_year":2018,"publication_date":"2018-06-28","ids":{"openalex":"https://openalex.org/W2810945895","doi":"https://doi.org/10.1016/j.ctrv.2018.06.018","mag":"2810945895","pmid":"https://pubmed.ncbi.nlm.nih.gov/30014952"},"language":"en","primary_location":{"id":"doi:10.1016/j.ctrv.2018.06.018","doi":"https://doi.org/10.1016/j.ctrv.2018.06.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2018.06.018","pdf_url":null,"source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ctrv.2018.06.018","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107887440","display_name":"Namita Sharma","orcid":"https://orcid.org/0009-0000-9280-0256","observed_orcids":["https://orcid.org/0009-0000-9280-0256"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Namita Sharma","raw_affiliation_strings":["Hematology/Medical Oncology, GCMC Cancer Center, 1800 Mulberry Street, Scranton, PA 18510, United States. Electronic address: dr.nams@gmail.com","Hematology/Medical Oncology, GCMC Cancer Center, 1800 Mulberry Street, Scranton, PA 18510, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Medical Oncology, GCMC Cancer Center, 1800 Mulberry Street, Scranton, PA 18510, United States. Electronic address: dr.nams@gmail.com","institution_ids":[]},{"raw_affiliation_string":"Hematology/Medical Oncology, GCMC Cancer Center, 1800 Mulberry Street, Scranton, PA 18510, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006274190","display_name":"Stephen L. Graziano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20388574","display_name":"SUNY Upstate Medical University","ror":"https://ror.org/040kfrw16","country_code":"US","type":"education","lineage":["https://openalex.org/I20388574"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen Graziano","raw_affiliation_strings":["SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States. Electronic address: grazians@upstate.edu","SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States. Electronic address: grazians@upstate.edu","institution_ids":["https://openalex.org/I20388574"]},{"raw_affiliation_string":"SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, United States","institution_ids":["https://openalex.org/I20388574"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006274190","https://openalex.org/A5107887440"],"corresponding_institution_ids":["https://openalex.org/I20388574"],"apc_list":{"value":4910,"currency":"USD","value_usd":4910},"apc_paid":{"value":4910,"currency":"USD","value_usd":4910},"fwci":0.7545,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.61658946,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"69","issue":null,"first_page":"143","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.949999988079071},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.9952360391616821},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9308665990829468},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8848732709884644},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8354852199554443},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7995374202728271},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6920815110206604},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6892530918121338},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6113971471786499},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4713439643383026},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4501205086708069},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4460219740867615},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.43764278292655945},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.429476797580719},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30028289556503296},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13876226544380188}],"mesh":[{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011838","descriptor_name":"Radiation-Sensitizing Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ctrv.2018.06.018","doi":"https://doi.org/10.1016/j.ctrv.2018.06.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2018.06.018","pdf_url":null,"source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},{"id":"pmid:30014952","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30014952","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reviews","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ctrv.2018.06.018","doi":"https://doi.org/10.1016/j.ctrv.2018.06.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2018.06.018","pdf_url":null,"source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1497402064","https://openalex.org/W1967394241","https://openalex.org/W2026951964","https://openalex.org/W2042278676","https://openalex.org/W2063391304","https://openalex.org/W2071539936","https://openalex.org/W2079251910","https://openalex.org/W2096198395","https://openalex.org/W2104056315","https://openalex.org/W2109567704","https://openalex.org/W2114095518","https://openalex.org/W2132540363","https://openalex.org/W2132870547","https://openalex.org/W2137043950","https://openalex.org/W2138851777","https://openalex.org/W2139804581","https://openalex.org/W2143859186","https://openalex.org/W2152905269","https://openalex.org/W2154149901","https://openalex.org/W2156353875","https://openalex.org/W2160336497","https://openalex.org/W2167571044","https://openalex.org/W2171139285","https://openalex.org/W2185481272","https://openalex.org/W2198093519","https://openalex.org/W2232632307","https://openalex.org/W2251438188","https://openalex.org/W2261163016","https://openalex.org/W2268267848","https://openalex.org/W2293531514","https://openalex.org/W2339311613","https://openalex.org/W2339922740","https://openalex.org/W2512922897","https://openalex.org/W2514360855","https://openalex.org/W2538232731","https://openalex.org/W2567564314","https://openalex.org/W2570618306","https://openalex.org/W2587420003","https://openalex.org/W2612006186","https://openalex.org/W2658185239","https://openalex.org/W2784012638","https://openalex.org/W2800751921","https://openalex.org/W2891970640","https://openalex.org/W6739726050"],"related_works":["https://openalex.org/W2004915982","https://openalex.org/W2078897254","https://openalex.org/W2327072759","https://openalex.org/W2110861505","https://openalex.org/W2078484622","https://openalex.org/W2080005755","https://openalex.org/W2075446507","https://openalex.org/W2098094886","https://openalex.org/W2612955291","https://openalex.org/W1833874039"],"abstract_inverted_index":{"Tyrosine":[0],"kinase":[1],"inhibitors":[2],"(TKIs)":[3],"have":[4],"emerged":[5],"as":[6,67,78,80],"first-line":[7,68],"treatment":[8,69],"for":[9,34],"the":[10,28,74,82,93,96],"management":[11],"of":[12,70],"epidermal":[13],"growth":[14],"factor":[15],"receptor":[16],"(EGFR)-mutated":[17],"advanced":[18,71],"non-small":[19],"cell":[20],"lung":[21,35],"cancer":[22,36],"(NSCLC).":[23],"Erlotinib":[24],"and":[25,37,84],"gefitinib":[26],"were":[27],"initial":[29],"TKIs":[30],"to":[31,57],"be":[32,58],"approved":[33],"showed":[38],"improved":[39],"response":[40],"rates":[41],"compared":[42],"with":[43],"chemotherapy.":[44],"Afatinib":[45,63],"is":[46],"an":[47],"irreversible":[48],"ErbB":[49],"family":[50],"blocker":[51],"that":[52],"has":[53,64],"also":[54],"been":[55,65],"shown":[56],"active":[59],"in":[60,73,81],"EGFR-mutated":[61],"NSCLC.":[62],"tested":[66],"NSCLC":[72],"LUX-Lung":[75,99],"trial":[76],"program,":[77],"well":[79],"second-":[83],"third-line":[85],"settings.":[86],"In":[87],"this":[88],"article,":[89],"we":[90],"will":[91],"review":[92],"data":[94],"from":[95],"8":[97],"reported":[98],"trials.":[100]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-07-10T00:00:00"}